Jeremy P.Cole

Partner

(T) + 1.312.269.4093

As a trial lawyer with 20 years of experience, Jeremy Cole has tried cases and defended clients in complex lawsuits and arbitrations around the world. He has handled contract disputes, international arbitrations, False Claims Act cases, state attorney general lawsuits, and product liability claims, among other matters.

Jeremy represents pharmaceutical and life science companies in various collaboration disputes, including development agreements, licensing agreements, and co-promotion agreements. He is currently lead counsel in a $300 million International Chamber of Commerce (ICC) arbitration arising from a development and commercialization collaboration. He also represents clients in licensing disputes, with amounts at issue ranging from eight figures to more than $1 billion. He was lead counsel for a multinational client in a post-acquisition dispute. Jeremy also obtained a defense verdict in a Fortune 150 client's first (and only) products liability trial for a significant product, deterring future claims.

He has defended a Fortune 150 client in several state attorney general actions asserting unfair and deceptive practice claims. Jeremy also defended a client charged with racketeering, mail and wire fraud, and other federal offenses in a three-month jury trial. He conducts internal investigations for multinational clients and defeated a nationwide class action and class arbitration brought simultaneously against a client in the precious metals industry.

Jeremy has appeared before tribunals in Europe and counsels clients on international agreements spanning Europe, Asia, and Latin America.

Jeremy is active in the Chicago community. He serves as board president of Working in the Schools (WITS), a literacy-focused nonprofit that mentors children in Chicago Public Schools.

Experience

  • Industry leader vindicated in class action and class arbitrationJones Day successfully represented an industry leader in a nationwide class action and related class arbitration involving five plaintiffs who filed a class action in federal court asserting various claims, including breach of contract, unfair business practices, and violations of various state consumer protection statutes.
  • Abbott wins defense verdict in first pharmaceutical products liability trial involving LupronJones Day successfully defended Abbott Laboratories ("Abbott") in a pharmaceutical products liability trial before a jury in federal court in Las Vegas involving the prescription drug, Lupron Depot 3.75 mg ("Lupron").
  • TAP wins summary judgment in pharmaceutical products liability suit in Alabama state courtJones Day successfully represented TAP Pharmaceutical Products Inc. in a pharmaceutical products liability lawsuit regarding Lupron Depot 3.75 mg, a drug prescribed to plaintiff after she was diagnosed with endometriosis.
  • Insurance broker defends DOJ prosecutionJones Day defended an insurance broker at trial in a RICO, insurance fraud, tax fraud, mail fraud, and wire fraud prosecution by the Department of Justice.
  • Abbott and TAP Pharmaceutical defend against Average Wholesale Price (AWP) litigationJones Day clients Abbott Laboratories and TAP Pharmaceutical Products, along with virtually the entire pharmaceutical industry, have been the subject of civil litigation alleging that drug manufacturers falsely reported the "average wholesale price," or "AWP," for various drugs in order to inflate the reimbursement paid by government and private payors for those drugs.
  • Speaking Engagements

    • July 29, 2014
      Defending Against New and Emerging Claims Relating to Credit, Debit, and Prepaid Cards and Bank Add-On Services and Products, ACI Consumer Finance Class Actions & Litigation Conference
    • January 30, 2014
      Defending Against New and Emerging Claims Relating to Credit, Debit, and Prepaid Cards and Bank Add-On Services and Products, ACI Consumer Finance Class Actions & Litigation Conference
    • October 9, 2013
      The New Normal of Consumer Finance Regulation and Compliance: Significant Trends for the Second Half of 2013
    • June 11, 2013
      CFPB Update: An Agency Begins to Find Its Regulatory Voice
    • June 6, 2013
      Complex Arbitration Today, Jones Day University
    • February 12, 2013
      CFPB Update: Enforcement Priorities and Best Practices Before an Evolving Bureau
    • June 7, 2012
      Jones Day Chicago 2012 MCLE University
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.